Company intelligence / Profile preview
Yooyoung Pharmaceutical
Seoul, Seoul Special City, South Korealinkedin.com ↗
- Ownership
- Private
- Employees
- ~14
- Development stage
- Commercial
01
Overview
Yooyoung Pharmaceutical is a South Korean pharmaceutical company and CDMO, known for its extensive portfolio of high-quality generic drugs, particularly sterile injectables and oral solid dosage forms. They also have an innovative pipeline, including a novel monoclonal antibody (YYB101) in Phase 1/2 for oncology indications.
- Therapeutic areas
- CardiovascularRheumatologyEndocrinologyWomen's HealthOncologyNeurology
- Modalities
- Small moleculeBiologicMonoclonal antibodyRecombinant protein
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Yooyoung Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yooyoung Pharmaceutical.